Ganciclovir, valganciclovir, foscarnet, and cidofovir: Reducing adverse events with renal impairment. (Quick Take) - Document - Gale OneFile: Health and Medicine
Ganciclovir Therapeutic Drug Monitoring in Obese Adults Patients - Opportunity for Clinical Utility - ATC Abstracts
![Safety of alternative antiviral agents for neonatal herpes simplex virus encephalitis and disseminated infection. - Abstract - Europe PMC Safety of alternative antiviral agents for neonatal herpes simplex virus encephalitis and disseminated infection. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4093668/bin/i1551-6776-19-2-72-t02.jpg)
Safety of alternative antiviral agents for neonatal herpes simplex virus encephalitis and disseminated infection. - Abstract - Europe PMC
![Maribavir for Treatment of Cytomegalovirus Infections Resistant or Refractory to Ganciclovir or Foscarnet in Hematopoietic Stem Cell Transplant or Solid Organ Transplant Recipients: A Randomized, Dose-Ranging, Double-Blind, Phase 2 Study - Biology Maribavir for Treatment of Cytomegalovirus Infections Resistant or Refractory to Ganciclovir or Foscarnet in Hematopoietic Stem Cell Transplant or Solid Organ Transplant Recipients: A Randomized, Dose-Ranging, Double-Blind, Phase 2 Study - Biology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2088318867/2074934163/ybbmt54544-fig-5001.jpg)